Concepedia

Richard Ingram

RI

Statistics

Publications

15

Citations

838

H-Index

14

Active since

1985

Affiliations

AIL Research (United States)(Current)

Richard Ingram is an author at AIL Research (United States) specializing in life sciences, enzyme inhibition, and medicinal chemistry.

Publications per year

1985–2014

15

Publications

15

Mechanism of Action and Epitopes of Clostridium difficile Toxin B-neutralizing Antibody Bezlotoxumab Revealed by X-ray Crystallography

Peter Orth, Li Xiao, Lorraine D. Hernandez et al. · Journal of Biological Chemistry · 2014 · 138 citations · Full text

, , +16

Discovery of the HCV NS3/4A Protease Inhibitor (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(<i>S</i>)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (Sch 503034) II. Key Steps in Structure-Based Optimization

Andrew Prongay, Zhuyan Guo, Nanhua Yao et al. · Journal of Medicinal Chemistry · 2007 · 108 citations · Full text

, , +13

A Continuous Spectrophotometric Assay for the Hepatitis C Virus Serine Protease

Rumin Zhang, Brian M. Beyer, James Durkin et al. · Analytical Biochemistry · 1999 · 91 citations

, , +8

Crystal Structure of the Catalytic Domain of Human ADAM33

Peter Orth, Paul Reichert, Wenyan Wang et al. · Journal of Molecular Biology · 2003 · 91 citations

, , +13

Serine Protease of Hepatitis C Virus Expressed in Insect Cells as the NS3/4A Complex

D. Šali, Richard Ingram, Michele Wendel et al. · Biochemistry · 1998 · 69 citations

, , +17

1–5 of 15